Steen Dalby Kristensen1*, MD, DMSc; Jean Fajadet2, MD; Carlo Di Mario3, MD; Zuzana Kaifoszova4, MD; Kristina Grønborg Laut1, MPH; Dan Deleanu5, MD; Martine Gilard6, MD, PhD; Giulio Guagliumi7, MD; Omer Goktekin8, MD; Julia Jorgova9, MD, PhD, FESC, FACC; John Kanakakis10, MD; Miodrag Ostojic11, MD, PhD, FESC, FACC, FSCAI; Helder Pereira12, MD, FESC, FACC, FSCAI; Manel Sabate13, MD, PhD; Mohamed Sobhy14, MD, FACC, FESC; Christiaan Vrints15, MD, PhD; William Wijns16, MD, PhD; Petr Widims
1. Department of Cardiology, Aarhus University Hospital, Skejby, Denmark; 2. Clinique Pasteur, Toulouse, France; 3. Cardiovascular Biomedical Research Unit, Royal Brompton Hospital, London, United Kingdom; 4. Stent for Life Initiative,
Aims: Primary percutaneous coronary intervention (PPCI) is the recommended treatment for patients with acute ST-segment elevation myocardial inf